Health Care: Drugs

Celgene Corp (CELG: NASDAQ)

$115.46 -2.62 | -2.22%
09/01/15 - 04:00 PM ET
Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 7.67B 6.49B 5.51B 4.84B
Cost of Sales 270.60M 229.10M 210.18M 352.23M
Gross Operating Profit 7.40B 6.26B 5.30B 4.49B
Selling, General, and Administrative Expenses 2.03B 1.68B 1.37B 1.23B
Research & Development 2.43B 2.23B 1.72B 1.60B
Operating Income before D & A (EBITDA) 2.94B 2.35B 2.20B 1.66B
Depreciation & Amortization 373.60M 374.10M 283.45M 362.85M
Interest Income 28.20M 0.00 15.26M 25.86M
Other Income - Net -92.40M -223.00M -17.01M -3.55M
Special Income / Charges 48.70M 171.10M -168.95M 284.69M
Total Income Before Interest Expenses (EBIT) 2.50B 1.76B 1.74B 1.46B
Interest Expense 176.10M 91.60M 63.20M 42.74M
Pre-Tax Income 2.33B 1.67B 1.68B 1.42B
Income Taxes 327.50M 215.50M 225.31M 102.07M
Minority Interest 0.00 0.00 0.00 -694.00K
Net Income From Continuing Operations 2.00B 1.45B 1.46B 1.32B
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 2.00B 1.45B 1.46B 1.32B
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 2.00B 1.45B 1.46B 1.32B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
2.00B 1.45B 1.63B 1.18B
Preferred Dividends
Net Income Available To Common 2.00B 1.45B 1.46B 1.32B
Basic EPS from Continuing Ops. 2.49 1.75 1.69 1.45
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 2.49 1.75 1.69 1.45
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 2.49 1.75 1.69 1.45
Basic Normalized Net Income/Share 2.49 1.75 1.89 1.29
EPS fr Continuing Ops. 2.39 1.68 1.65 1.42
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 2.39 1.68 1.65 1.42
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 2.39 1.69 1.65 1.43
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
2.39 1.68 1.84 1.27
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with CELG

Latest CELG Headlines from TheStreet

More Financial News for CELG

Press Releases for CELG

See All Press Releases

Partner Headlines for CELG

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter